Switch to:
More From Other Websites
AstraZeneca, Daiichi Sankyo to Co-Market Movantik in U.S. - Analyst Blog Mar 20 2015
AstraZeneca, Daiichi Sankyo to Sell Constipation Drug in U.S. Mar 19 2015
AstraZeneca And Daiichi Sankyo To Jointly Commercialise MOVANTIK In The US Mar 19 2015
AstraZeneca And Daiichi Sankyo To Jointly Commercialise MOVANTIK In The US Mar 19 2015
Oracle and Adobe are big market movers Mar 18 2015
Bernstein Liebhard LLP Investigates Claims On Behalf Of Those Who Invested In Nektar Therapeutics Mar 18 2015
Nektar Therapeutics (NKTR) Stock Tanks Today on Failed Phase III Breast Cancer Treatment Results Mar 18 2015
Biotech Stock Roundup: Amgen & Regeneron Shine at ACC, Nektar Drug Disappoints - Analyst Blog Mar 18 2015
Nektar's Breast Cancer Candidate Fails in BEACON Study - Analyst Blog Mar 18 2015
What We’re Trading Mar 18 2015
Early movers: FDX, GIS, ORCL, MSFT, HLF & more Mar 18 2015
Tuesday's After-Hours Movers: Oracle, Papa Murphy's And More Mar 17 2015
Akorn Leads 5 Drug Stocks Moving After Hours On News Mar 17 2015
Breast cancer drug, key to Nektar growth plans, fails clinical trial Mar 17 2015
NEKTAR THERAPEUTICS Files SEC form 8-K, Regulation FD Disclosure Mar 17 2015
Etirinotecan Pegol (NKTR-102) Prolonged Median Overall Survival by 2.1 Months versus Active Control... Mar 17 2015
Nektar drug fails late-stage study in breast cancer patients Mar 17 2015
Etirinotecan Pegol (NKTR-102) Prolonged Median Overall Survival by 2.1 Months versus Active Control... Mar 17 2015
NEKTAR THERAPEUTICS Files SEC form 10-K, Annual Report Feb 26 2015
Nektar Therapeutics Incurs Narrower-than-Expected Q4 Loss - Analyst Blog Feb 25 2015


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK